Literature DB >> 10691291

Expression of aspartoacylase activity in cultured rat macroglial cells is limited to oligodendrocytes.

M H Baslow1, R F Suckow, V Sapirstein, B L Hungund.   

Abstract

N-acetyl-L-aspartate (NAA) is an important osmolyte in the vertebrate brain and eye, and its cyclical metabolism is accomplished in two separate compartments. In the brain, NAA is synthesized primarily in neurons, and after its regulated release, NAA is hydrolyzed by aspartoacylase, which is present in a glial-associated compartment. However, the precise nature of this hydrolytic compartment has remained obscure. It has been proposed that one role of aspartoacylase in the central nervous system (CNS) is as part of a molecular water pump (MWP) that uses the NAA intercompartmental cycle to remove nerve cell metabolic water against a water gradient and that oligodendrocytes comprise the second compartment in this metabolic sequence. The absence of aspartoacylase activity in Canavan disease (CD), a rare early onset genetic spongiform leukodystrophy, is associated with CNS edema, intramyelinic swelling and a progressive loss of oligdendrocytes. In order to evaluate the MWP hypothesis and its possible relationship to the etiology of CD further, both oligodendrocytes and astrocytes obtained from neonatal rat brain were grown in culture and tested for the presence of aspartoacylase activity. The results of this study show for the first time that aspartoacylase activity is expressed only in oligodendrocytes. The meaning of this observation in understanding the function of the NAA metabolic cycle is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10691291     DOI: 10.1385/JMN:13:1-2:47

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  22 in total

Review 1.  Molecular water pumps and the aetiology of Canavan disease: a case of the sorcerer's apprentice.

Authors:  M H Baslow
Journal:  J Inherit Metab Dis       Date:  1999-04       Impact factor: 4.982

Review 2.  The existence of molecular water pumps in the nervous system: a review of the evidence.

Authors:  M H Baslow
Journal:  Neurochem Int       Date:  1999-01       Impact factor: 3.921

3.  Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo.

Authors:  T E Bates; M Strangward; J Keelan; G P Davey; P M Munro; J B Clark
Journal:  Neuroreport       Date:  1996-05-31       Impact factor: 1.837

4.  The human Na+-glucose cotransporter is a molecular water pump.

Authors:  A Meinild; D A Klaerke; D D Loo; E M Wright; T Zeuthen
Journal:  J Physiol       Date:  1998-04-01       Impact factor: 5.182

5.  Identification of N-acetylaspartate in the lens of the vertebrate eye: a new model for the investigation of the function of N-acetylated amino acids in vertebrates.

Authors:  M H Baslow; S Yamada
Journal:  Exp Eye Res       Date:  1997-02       Impact factor: 3.467

6.  Protracted form of spongy degeneration of the central nervous system (van Bogaert and Bertrand type).

Authors:  M Adachi; B W Volk
Journal:  Neurology       Date:  1968-11       Impact factor: 9.910

Review 7.  N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain.

Authors:  D L Birken; W H Oldendorf
Journal:  Neurosci Biobehav Rev       Date:  1989       Impact factor: 8.989

Review 8.  Canavan disease. Analysis of the nature of the metabolic lesions responsible for development of the observed clinical symptoms.

Authors:  M H Baslow; T R Resnik
Journal:  J Mol Neurosci       Date:  1997-10       Impact factor: 3.444

Review 9.  A review of phylogenetic and metabolic relationships between the acylamino acids, N-acetyl-L-aspartic acid and N-acetyl-L-histidine, in the vertebrate nervous system.

Authors:  M H Baslow
Journal:  J Neurochem       Date:  1997-04       Impact factor: 5.372

10.  Function of the N-acetyl-L-histidine system in the vertebrate eye. Evidence in support of a role as a molecular water pump.

Authors:  M H Baslow
Journal:  J Mol Neurosci       Date:  1998-06       Impact factor: 3.444

View more
  26 in total

1.  Expression and localization of myosin-1d in the developing nervous system.

Authors:  Andrew E Benesh; Jonathan T Fleming; Chin Chiang; Bruce D Carter; Matthew J Tyska
Journal:  Brain Res       Date:  2012-01-08       Impact factor: 3.252

2.  Reversed-phase HPLC with UV detection for the determination of N-acetylaspartate and creatine.

Authors:  Mattias Tranberg; Malin H Stridh; Barbro Jilderos; Stephen G Weber; Mats Sandberg
Journal:  Anal Biochem       Date:  2005-03-30       Impact factor: 3.365

3.  Redirecting N-acetylaspartate metabolism in the central nervous system normalizes myelination and rescues Canavan disease.

Authors:  Dominic J Gessler; Danning Li; Hongxia Xu; Qin Su; Julio Sanmiguel; Serafettin Tuncer; Constance Moore; Jean King; Reuben Matalon; Guangping Gao
Journal:  JCI Insight       Date:  2017-02-09

Review 4.  N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.

Authors:  John R Moffett; Brian Ross; Peethambaran Arun; Chikkathur N Madhavarao; Aryan M A Namboodiri
Journal:  Prog Neurobiol       Date:  2007-01-05       Impact factor: 11.685

5.  Rescuing Canavan disease: engineering the wrong cell at the right time.

Authors:  Morris H Baslow
Journal:  J Inherit Metab Dis       Date:  2017-04-03       Impact factor: 4.982

6.  Long-term follow-up after gene therapy for canavan disease.

Authors:  Paola Leone; David Shera; Scott W J McPhee; Jeremy S Francis; Edwin H Kolodny; Larissa T Bilaniuk; Dah-Jyuu Wang; Mitra Assadi; Olga Goldfarb; H Warren Goldman; Andrew Freese; Deborah Young; Matthew J During; R Jude Samulski; Christopher G Janson
Journal:  Sci Transl Med       Date:  2012-12-19       Impact factor: 17.956

7.  Nur7 is a nonsense mutation in the mouse aspartoacylase gene that causes spongy degeneration of the CNS.

Authors:  Maria Traka; Robert L Wollmann; Sonia R Cerda; Jason Dugas; Ben A Barres; Brian Popko
Journal:  J Neurosci       Date:  2008-11-05       Impact factor: 6.167

8.  Brain damage results in down-regulation of N-acetylaspartate as a neuronal osmolyte.

Authors:  Morris H Baslow; Raymond F Suckow; Kate Gaynor; Kishore K Bhakoo; Neville Marks; Mariko Saito; Mitsuo Saito; Karen Duff; Yasuji Matsuoka; Martin J Berg
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

9.  Myelin lipid abnormalities in the aspartoacylase-deficient tremor rat.

Authors:  Jianfeng Wang; Paola Leone; Gusheng Wu; Jeremy S Francis; Hong Li; Mohit Raja Jain; Tadao Serikawa; Robert W Ledeen
Journal:  Neurochem Res       Date:  2008-05-14       Impact factor: 3.996

10.  Measuring N-acetylaspartate synthesis in vivo using proton magnetic resonance spectroscopy.

Authors:  Su Xu; Jehoon Yang; Jun Shen
Journal:  J Neurosci Methods       Date:  2008-04-10       Impact factor: 2.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.